Your browser doesn't support javascript.
loading
V180I genetic Creutzfeldt-Jakob disease: Severe degeneration of the inferior olivary nucleus in an autopsied patient with identification of the M2T prion strain.
Watanabe, Midori; Nakamura, Kosei; Saito, Rie; Takeuchi, Atsuko; Takahashi, Tetsuya; Kitamoto, Tetsuyuki; Onodera, Osamu; Kakita, Akiyoshi.
Affiliation
  • Watanabe M; Department of Pathology, Brain Research Institute, Niigata University, Niigata, Japan.
  • Nakamura K; Undergraduate Course, Niigata University School of Medicine, Niigata, Japan.
  • Saito R; Department of Neurology, NHO Nishiniigata Chuo Hospital, Niigata, Japan.
  • Takeuchi A; Department of Neurology, Brain Research Institute, Niigata University, Niigata, Japan.
  • Takahashi T; Department of Pathology, Brain Research Institute, Niigata University, Niigata, Japan.
  • Kitamoto T; Department of Neurological Science, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Onodera O; Department of Neurology, NHO Nishiniigata Chuo Hospital, Niigata, Japan.
  • Kakita A; Department of Neurological Science, Tohoku University Graduate School of Medicine, Sendai, Japan.
Neuropathology ; 43(6): 479-485, 2023 Dec.
Article in En | MEDLINE | ID: mdl-37165430
ABSTRACT
Genetic Creutzfeldt-Jakob disease (gCJD) with a V180I mutation (V180I gCJD) is the most common type of gCJD in Japan, characterized by an older age at onset, slower progression, and moderate to severe cortical degeneration with spongiform changes and sparing of the brainstem and cerebellum. Degeneration of the inferior olivary nucleus (IO) is rarely observed in patients with CJD but is known to occur in fatal familial insomnia (FFI) and MM2-thalamic-type sporadic CJD (sCJD-MM2T) involving type 2 prion protein (M2T prion). Here we report on an 81-year-old Japanese woman who initially developed depressive symptoms followed by progressive cognitive impairment, myoclonus, and hallucinations and died after a clinical course of 23 months. Insomnia was not evident. Genetic analysis of the prion protein (PrP) identified a V180I mutation with methionine/valine heterozygosity at codon 129. Pathologic analysis demonstrated extensive spongiform degeneration, neuronal loss in the cortices, and weak synaptic-type PrP deposition. Except for IO degeneration, the clinicopathologic features and Western blotting PrP band pattern were compatible with those of previously reported V180I gCJD cases. Quantitative analysis revealed that the neuronal density of the IO, especially in the dorsal area, was considerably reduced to the same extent as that of a patient with sCJD-MM2T but preserved in other patients with V180I gCJD and sCJD-MM1 (this patient, 2.3 ± 0.53/mm2 ; a patient with sCJD-MM2T, 4.2 ± 2; a patient with V180I gCJD, 60.5 ± 9.3; and a patient with sCJD-MM1, 84.5 ± 17.9). Use of the protein misfolding cyclic amplification (PMCA) method confirmed the presence of the M2T prion strain, suggesting that the latter might be associated with IO degeneration in V180I gCJD. Autopsy studies are necessary to better understand the nature of CJD, since even if patients present with the common clinical picture, pathologic analysis might provide new insights, as was the case here.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prions / Creutzfeldt-Jakob Syndrome Type of study: Diagnostic_studies / Prognostic_studies Limits: Aged80 / Female / Humans Language: En Journal: Neuropathology Journal subject: NEUROLOGIA / PATOLOGIA Year: 2023 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prions / Creutzfeldt-Jakob Syndrome Type of study: Diagnostic_studies / Prognostic_studies Limits: Aged80 / Female / Humans Language: En Journal: Neuropathology Journal subject: NEUROLOGIA / PATOLOGIA Year: 2023 Document type: Article Affiliation country: